dc.contributor.author | Anak, S | |
dc.contributor.author | Bilge, I | |
dc.contributor.author | Unuvar, A | |
dc.contributor.author | Devecioglu, O | |
dc.contributor.author | Ander, H | |
dc.contributor.author | Ziylan, O | |
dc.date.accessioned | 2021-03-03T13:54:44Z | |
dc.date.available | 2021-03-03T13:54:44Z | |
dc.date.issued | 2003 | |
dc.identifier.citation | Devecioglu O., Unuvar A., Anak S., Bilge I., Ander H., Ziylan O., "Pyelolithotomy in a patient with Glanzmann thrombasthenia and antiglycoprotein IIb/IIIa antibodies: the shortest possible duration of treatment with recombinant activated factor VII and platelet transfusions", TURKISH JOURNAL OF PEDIATRICS, cilt.45, sa.1, ss.64-66, 2003 | |
dc.identifier.issn | 0041-4301 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_36c14af8-d541-4356-860a-825c91bcbc52 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/40950 | |
dc.description.abstract | Transfusion of platelet concentrates remains the first-line therapy for Glanzmann thrombasthenia in case of bleeding or preparation for surgery. However, development of antibodies to platelet glycoprotein (Gp) IIb/IIIa complex or human leukocyte antigens (HLA) is frequent and the main cause of platelet refractoriness. Recombinant activated factor VII (rFVIIa) is a potent alternative for patients with Glanzmann thrombasthenia with anti-platelet antibodies. | |
dc.language.iso | eng | |
dc.subject | Tıp | |
dc.subject | Çocuk Sağlığı ve Hastalıkları | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Klinik Tıp | |
dc.subject | PEDİATRİ | |
dc.title | Pyelolithotomy in a patient with Glanzmann thrombasthenia and antiglycoprotein IIb/IIIa antibodies: the shortest possible duration of treatment with recombinant activated factor VII and platelet transfusions | |
dc.type | Makale | |
dc.relation.journal | TURKISH JOURNAL OF PEDIATRICS | |
dc.contributor.department | İstanbul Üniversitesi , İstanbul Tıp Fakültesi , Cerrahi Tıp Bilimleri Bölümü | |
dc.identifier.volume | 45 | |
dc.identifier.issue | 1 | |
dc.identifier.startpage | 64 | |
dc.identifier.endpage | 66 | |
dc.contributor.firstauthorID | 166841 | |